This CTD dossier owner and manufacturer, established over three decades ago in South Asia, has become a prominent player in the global pharmaceutical market. Their focus lies in manufacturing and exporting a wide array of pharmaceutical products, including prescription and over-the-counter medications, to regulated and non-regulated markets worldwide. They have a strong presence in regions like Latin America, the Middle East, CIS, and Asia, with a subsidiary established in the Caucasus. Their commitment to quality is evident through adherence to WHO GMP standards, along with EU and USFDA guidelines. They specialize in manufacturing solid dosage forms and have a diverse range of therapeutic areas, although specific details were not provided.

Established in 1996, this Manufacturer is a WHO-GMP and ISO-certified CTD dossier owner and manufacturer, employing between 101 to 250 professionals. As a GMP manufacturer, it operates dedicated production lines for cephalosporins, beta-lactam, penam, general dry powder injections, ophthalmic solutions, and liquid injectables in ampoules, vials, pre-filled syringes, and dental cartridges. With a portfolio exceeding 250 formulations, the Manufacturer exports products to over 44 countries and regions worldwide. As a CTD dossier owner and manufacturer, it upholds stringent GMP standards across all operations. Committed to global health, this GMP manufacturer continues to expand its presence in regulated markets.